微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.06% | 13.32% | 47.39% | 49/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.79% | 34.55% | 64.6% | 39/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.91% | 34.72% | 609.76% | 37/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 0.41% | -90.24% | -93.42% | 102/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 6.23% | 74.02% | 75% | 54/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.56% | 78.89% | 64.81% | 60/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.16% | 118.18% | -48.57% | 59/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.2% | 150.85% | 17.32% | 81/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.58% | -16.55% | 79.9% | 77/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.99% | -12.33% | 101.01% | 87/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.99% | -33.56% | 111.99% | 91/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -8.26% | -279.96% | -292.54% | 131/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 4.29% | -10.81% | 88.99% | 84/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.27% | -26.54% | 52.35% | 94/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.49% | -12.35% | -67.54% | 80/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4.59% | -32.3% | -4.57% | 90/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 4.81% | -18.89% | 55.66% | 72/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 3.09% | -18.47% | 81.76% | 74/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.7% | -14.57% | -74.93% | 58/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 6.78% | 169.25% | 14.33% | 77/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 5.93% | 9.61% | 56.46% | 61/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.79% | 1.88% | 90.45% | 63/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.99% | -5.24% | 120.33% | 56/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -9.79% | -250.85% | -280.96% | 125/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.41% | -7.68% | 45.43% | 64/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.72% | -15.65% | 77.14% | 62/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.1% | -6.67% | -67.64% | 52/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 6.49% | -13.47% | 10.75% | 75/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.86% | -5.64% | 32.88% | 58/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.41% | 19.84% | 96% | 54/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.25% | 58.45% | -70% | 39/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 7.5% | 154.24% | 20.77% | 69/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6.21% | 150.4% | 68.75% | 44/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 3.68% | 178.79% | 159.15% | 53/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.42% | 184% | -51.86% | 52/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 2.95% | 14.34% | 18.95% | 83/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 2.48% | 14.81% | 87.88% | 60/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 1.32% | -30.16% | 164% | 62/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.5% | -46.24% | -80.62% | 61/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |